BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 32530761)

  • 1. Improved Risk Prediction Calculator for Sentinel Node Positivity in Patients With Melanoma: The Melanoma Institute Australia Nomogram.
    Lo SN; Ma J; Scolyer RA; Haydu LE; Stretch JR; Saw RPM; Nieweg OE; Shannon KF; Spillane AJ; Ch'ng S; Mann GJ; Gershenwald JE; Thompson JF; Varey AHR
    J Clin Oncol; 2020 Aug; 38(24):2719-2727. PubMed ID: 32530761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting sentinel node positivity in patients with melanoma: external validation of a risk-prediction calculator (the Melanoma Institute Australia nomogram) using a large European population-based patient cohort.
    El Sharouni MA; Varey AHR; Witkamp AJ; Ahmed T; Sigurdsson V; van Diest PJ; Scolyer RA; Thompson JF; Lo SN; van Gils CH
    Br J Dermatol; 2021 Aug; 185(2):412-418. PubMed ID: 33657653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population-Based Validation of the MIA and MSKCC Tools for Predicting Sentinel Lymph Node Status.
    Olofsson Bagge R; Mikiver R; Marchetti MA; Lo SN; van Akkooi ACJ; Coit DG; Ingvar C; Isaksson K; Scolyer RA; Thompson JF; Varey AHR; Wong SL; Lyth J; Bartlett EK
    JAMA Surg; 2024 Mar; 159(3):260-268. PubMed ID: 38198163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are the MIA and MSKCC nomograms useful in selecting patients with melanoma for sentinel lymph node biopsy?
    Hosein S; Drebin HM; Kurtansky NR; Olofsson Bagge R; Coit DG; Bartlett EK; Marchetti MA
    J Surg Oncol; 2023 Jun; 127(7):1167-1173. PubMed ID: 36905337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for sentinel lymph node metastasis and validation study of the MSKCC nomogram in breast cancer patients.
    Qiu PF; Liu JJ; Wang YS; Yang GR; Liu YB; Sun X; Wang CJ; Zhang ZP
    Jpn J Clin Oncol; 2012 Nov; 42(11):1002-7. PubMed ID: 23100610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of the Melanoma Institute of Australia's Sentinel Lymph Node Biopsy Risk Prediction Tool for Cutaneous Melanoma.
    Maddineni S; Dizon MP; Muralidharan V; Young LA; Sunwoo JB; Baik FM; Swetter SM
    Ann Surg Oncol; 2024 Apr; 31(4):2737-2746. PubMed ID: 38216800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of an existing and modified model for predicting non sentinel lymph node metastasis in breast cancer patients with positive sentinel node biopsy.
    Al-Masri M; Darwazeh G; El-Ghanem M; Hamdan B; Sughayer M
    Gulf J Oncolog; 2013 Jan; 1(13):15-22. PubMed ID: 23339977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative validation of online nomograms for predicting nonsentinel lymph node status in sentinel lymph node-positive breast cancer.
    Hessman CJ; Naik AM; Kearney NM; Jensen AJ; Diggs BS; Troxell ML; Vetto JT
    Arch Surg; 2011 Sep; 146(9):1035-40. PubMed ID: 21931000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of Memorial Sloan-Kettering Cancer Center nomogram for prediction of non-sentinel lymph node metastasis in sentinel lymph node positive breast cancer patients an international comparison.
    Kuo YL; Chen WC; Yao WJ; Cheng L; Hsu HP; Lai HW; Kuo SJ; Chen DR; Chang TW
    Int J Surg; 2013; 11(7):538-43. PubMed ID: 23707626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting the likelihood of additional lymph node metastasis in sentinel lymph node positive breast cancer: validation of the Memorial Sloan-Kettering Cancer Centre (MSKCC) nomogram.
    Chue KM; Yong WS; Thike AA; Ahmed SS; Li HH; Wong CY; Ho GH; Madhukumar P; Tan BK; Ong KW; Tan PH
    J Clin Pathol; 2014 Feb; 67(2):112-9. PubMed ID: 24048026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of a nomogram predicting sentinel lymph node status in melanoma in an Irish population.
    Woods JF; De Marchi JA; Lowery AJ; Hill AD
    Ir J Med Sci; 2015 Dec; 184(4):769-73. PubMed ID: 24997756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multicenter prospective evaluation of the reliability of the combined use of two models to predict non-sentinel lymph node status in breast cancer patients with metastatic sentinel lymph nodes: the MSKCC nomogram and the Tenon score. Results of the NOTEGS study.
    Rouzier R; Uzan C; Rousseau A; Guillot E; Zilberman S; Meyer C; Estevez P; Dupre PF; Kere D; Doridot V; D'halluin G; Fritel X; Pouget N; Jankowski C; Mazouni C; Simon T; Coutant C
    Br J Cancer; 2017 Apr; 116(9):1135-1140. PubMed ID: 28324891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison of three models to predict non-sentinel lymph node status in breast cancer patients with metastatic sentinel lymph nodes: a retrospective study of 77 patients].
    Terrier C; Tariel O; Coutant C; De Saint Hilaire P; Devouassoux M; Rudigoz RC; Dubernard G
    J Gynecol Obstet Biol Reprod (Paris); 2012 May; 41(3):227-34. PubMed ID: 22464015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of a Nomogram for Non-sentinel Node Positivity in Melanoma Patients, and Its Clinical Implications: A Brazilian-Dutch Study.
    Bertolli E; Franke V; Calsavara VF; de Macedo MP; Pinto CAL; van Houdt WJ; Wouters MWJM; Duprat Neto JP; van Akkooi ACJ
    Ann Surg Oncol; 2019 Feb; 26(2):395-405. PubMed ID: 30456681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of a nomogram to predict the risk of nonsentinel lymph node metastases in breast cancer patients with a positive sentinel node biopsy: validation of the MSKCC breast nomogram.
    van la Parra RF; Ernst MF; Bevilacqua JL; Mol SJ; Van Zee KJ; Broekman JM; Bosscha K
    Ann Surg Oncol; 2009 May; 16(5):1128-35. PubMed ID: 19252954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of a nomogram to predict the presence of sentinel lymph node metastases in melanoma.
    Piñero A; Canteras M; Ortiz E; Martínez-Barba E; Parrilla P
    Ann Surg Oncol; 2008 Oct; 15(10):2874-7. PubMed ID: 18648880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sentinel lymph node micrometastasis and risk of non-sentinel lymph node metastasis: validation of two breast cancer nomograms.
    D'Eredità G; Troilo VL; Giardina C; Napoli A; Rubini G; Fischetti F; Berardi T
    Clin Breast Cancer; 2010 Dec; 10(6):445-51. PubMed ID: 21147687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. External validation of the Melanoma Institute Australia Sentinel Node Metastasis Risk Prediction Tool using the National Cancer Database.
    Freeman SC; Paz Munoz E; Latour E; Lim JY; Yu W
    J Am Acad Dermatol; 2023 Nov; 89(5):967-973. PubMed ID: 37454700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of Memorial Sloan Kettering Cancer Center nomogram to detect non-sentinel lymph node metastases in a United Kingdom cohort.
    Syed A; Eleti S; Kumar V; Ahmad A; Thomas H
    G Chir; 2018; 39(1):12-19. PubMed ID: 29549676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Good prediction of the likelihood for sentinel lymph node metastasis by using the MSKCC nomogram in a German breast cancer population.
    Klar M; Foeldi M; Markert S; Gitsch G; Stickeler E; Watermann D
    Ann Surg Oncol; 2009 May; 16(5):1136-42. PubMed ID: 19259742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.